Cancer Genetics Inc (NASDAQ:CGIX)

Delayed Data
As of 12:54pm ET
 +0.435 / +3.99%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 15.38, with a high estimate of 15.80 and a low estimate of 13.00. The median estimate represents a +35.52% increase from the last price of 11.35.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.80%
Growthannually -9.94%


Growthquarterly 4.67%
Growthannually 105.77%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account